+
Zydus Gets USFDA Clearance for Ankleshwar API Plant
ECONOMY & POLICY

Zydus Gets USFDA Clearance for Ankleshwar API Plant

Zydus has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat. The facility underwent a comprehensive inspection by the USFDA from 10th to 14th March 2025.

The inspection has been classified as “No Action Indicated” (NAI), confirming that no objectionable conditions or practices were found during the review. The agency has now officially closed the inspection process.

This update has been disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The receipt of the EIR underscores Zydus’s ongoing commitment to maintaining global quality standards at its manufacturing sites. It also reinforces the company’s regulatory track record and strengthens its position in the US pharmaceutical market.

Zydus has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat. The facility underwent a comprehensive inspection by the USFDA from 10th to 14th March 2025.The inspection has been classified as “No Action Indicated” (NAI), confirming that no objectionable conditions or practices were found during the review. The agency has now officially closed the inspection process.This update has been disclosed in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.The receipt of the EIR underscores Zydus’s ongoing commitment to maintaining global quality standards at its manufacturing sites. It also reinforces the company’s regulatory track record and strengthens its position in the US pharmaceutical market.

Next Story
Real Estate

No glass boxes!

India is moving away from the ‘glass box’ syndrome, all-glass façades that were widely used in commercial buildings in the last two decades but came at a significant environmental cost given the country’s predominantly hot and humid climate. Poor thermal performance, excessive heat gain and dependency on mechanical cooling systems made buildings with glass façades energy guzzlers and significantly increased their carbon footprint.That said, it’s important to be aware that “glass is not the enemy,” points out Heena Bhargava, Architect, Architecture Discipline. “How it ..

Next Story
Infrastructure Transport

Why do pavements fail?

India’s highways continue to expand at a healthy pace. But conversations on the surface quality of highways are growing louder because major deficiencies and black spots continue to be identified, and they are cause for concern.“Road surface roughness causes vehicle vibrations that, in turn, can affect the performance of drivers,” explains Dr V K Gahlot, Road Safety Auditor, Centre for Research and Sustainable Development (CfRSD). “Continuous exposure may induce fatigue, a contributory factor to road accidents. Road surface roughness also affects the vehicle operating cost...

Next Story
Infrastructure Urban

APAC Logistics Rents Fall for First Time Since 2020

Logistics rents across the Asia-Pacific region declined 0.4% year-on-year in H1 2025, marking the first annual drop since 2020, according to Knight Frank’s Logistics Highlights H1 2025 report. Despite global trade tensions and cautious occupier sentiment, India emerged as a standout performer, driven by robust manufacturing momentum and supply chain recalibration.Regional Trends and DivergenceWhile rents largely remained stable across most markets, regional differences became more pronounced:Mainland China continued to see rental declines, though the pace of decline moderated to 12.8% YoY, s..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?